eMed Test-to-Treat app for iPhone and iPad

Our Mission is Simple. eMed® - Democratizing Healthcare™

To realize this mission, we’ve made it possible for anyone, anywhere, to receive certified COVID-19 lab results and treatment— all from the comfort of your home using devices you already own.

Testing is accessible worldwide with the helpful 24/7 live support of eMed’s Certified Guides. Your Certified Guide will issue you a lab report accepted by select international airlines, cruise lines, or any organization that requires a CDC approved antigen test result.

We make COVID-19 treatment even easier with our world-first Test-to-Treat™ program. After completing your test, we can connect you with a partner clinician who will review your results and, if eligible, send a prescription for treatment to a local pharmacy of your choice.

eMed will continue to make healthcare more affordable and accessible with new Test-to-Treat™ programs in the future. Check back soon for testing and treatment of Flu, UTI, and other common infections.

Join the millions of people who have already experienced how safe and easy it is to travel, work, and gather with eMed.

Features:
- Access virtually-proctored at-home COVID-19 testing platform
- Receive verified test results and access to treatment within minutes from anywhere
- Obtain access to certified lab report sent via email at any time
- Use eMed certified lab report for entry and reentry into the U.S., as well as boarding select international airlines and cruise lines

This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.